Item 1. Security and Issuer.
This joint statement on Schedule 13D/A (this Statement) is filed with respect to the Common Stock, par value $0.001 per share
(Common Stock), of RxSight, Inc., a Delaware corporation (the Issuer). The address of the principal executive offices of the Issuer is 100 Columbia, Aliso Viejo, CA 92656.
Item 2. Identity and Background.
(a) This Amendment
No. 2 (Amendment) is being filed by Longitude Venture Partners II, L.P. (LVPII), Longitude Capital Partners II, LLC (LCPII), Longitude Prime Fund, L.P. (LPF), Longitude
Prime Partners, LLC (LPP and together with LVPII, LCPII and LPF, the Reporting Entities) and Juliet Tammenoms Bakker (Tammenoms Bakker), a member of the Issuers board of directors (the
Board), and Patrick G. Enright (Enright and together with Tammenoms Bakker, the Reporting Individuals). This Amendment amends and supplements the Schedule 13D originally filed with the
Commission on August 13, 2021 and Amendment No. 1 filed with the Commission on June 5, 2023 (the Original Schedule 13D). The Reporting Entities and the Reporting Individuals are collectively referred to as the
Reporting Persons. The agreement among the Reporting Persons to file jointly in accordance with the provisions of Rule 13d-1(k)(1) under the Act is attached to the Original Schedule 13D as
Exhibit 1. Each Reporting Person disclaims beneficial ownership of all securities reported in this Statement except to the extent of such Reporting Persons pecuniary interest therein, other than those securities reported herein as being
held directly by such Reporting Person. Only those items that are hereby reported are amended; all other items reported in the Original Schedule 13D remain unchanged. Information given in response to each item shall be deemed incorporated by
reference in all other items, as applicable. Capitalized terms not defined in this Amendment have the meanings ascribed to them in the Original Schedule 13D.
Item 5. Interest in Securities of the Issuer.
Item
5 of the Original Schedule 13D is hereby amended to add the following language:
(a) and (b) See Items 7-11 of
the cover pages of this Amendment and Item 2 above.
(c)
On June 14, 2023, LPF effected a pro rata distribution without additional consideration of 267,300 shares of Common Stock to (i) LPP, its
general partner and (ii) its limited partners. LPP then effected a pro rata distribution without additional consideration of the shares that it received in connection with such distribution to its members.
On August 9, 2023, LVPII effected a pro rata distribution without additional consideration of 497,150 shares of Common Stock to (i) LCPII,
its general partner and (ii) its limited partners. LCPII then effected a pro rata distribution without additional consideration of the shares that it received in connection with such distribution to its members.
On August 17, 2023, Tammenoms Bakker sold 18,484 shares of Common Stock for a weighted-average sale price of $30.0635 per share for an aggregate sale
price of $555,694.57.
On August 18, 2023, Tammenoms Bakker sold 14,651 shares of Common Stock for a weighted-average sale price of $ 29.0681 per
share for an aggregate sale price of $425,876.34.
(e) On August 18, 2023, each of the Reporting Persons ceased to be the beneficial owner of more
than five percent of the outstanding shares of Common Stock. When rounded to the nearest thousandth, the percent of Common Stock represented by Enrights beneficial ownership is 4.979%. When rounded to the nearest thousandth, the percent of
Common Stock represented by Tammenom Bakkers beneficial ownership is 4.966%.